PTC Therapeutics
PTCT
#2761
Rank
C$8.50 B
Marketcap
C$105.96
Share price
-0.08%
Change (1 day)
61.41%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: C$8.50 Billion

As of January 2026 PTC Therapeutics has a market cap of C$8.50 Billion. This makes PTC Therapeutics the world's 2761th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$8.50 B-1.51%
2025C$8.63 B72.56%
2024C$5.00 B81.47%
2023C$2.75 B-27.02%
2022C$3.77 B5.33%
2021C$3.58 B-32.42%
2020C$5.30 B36.67%
2019C$3.88 B64.22%
2018C$2.36 B171.92%
2017C$0.87 B72.92%
2016C$0.50 B-66.99%
2015C$1.52 B-22.87%
2014C$1.97 B359.65%
2013C$0.42 B

End of Day market cap according to different sources

On Jan 6th, 2026 the market cap of PTC Therapeutics was reported to be:

C$8.50 Billion
by Nasdaq info icon info icon
C$8.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Vertex Pharmaceuticals
VRTX
C$165.89 B 1,850.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.23 B-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.16 B-98.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
C$15.03 B 76.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$1.38 B-83.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$377.11 B 4,332.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland